pharma
Bracco Imaging S.p.A
Bracco Imaging S.p.A.
Bracco Imaging S.p.A patent portfolio β 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Milano, IT
- Programs
- 0
- Drugs
- 0
- Patents
- 25
Bracco Imaging S.p.A patents
25 pharmaceutical patents indexed for Bracco Imaging S.p.A. 0 expire within 24 months.
Bracco Imaging S.p.A has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months β use filters for patent-cliff planning.
Patent portfolio
-
CN 119365549
Fluorescent probe targeting CA-IX
granted -
CN 119343336
1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents
granted -
CN 119325492
Fluorescent probe targeting CA-IX
granted -
CN 118401500
Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes
granted -
US 2024131199
PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20240034693
μ΄λ체 μ‘°μμ μ μ μ‘°
granted -
US 2023312523
NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20230116805
κ°λν 리λ μ μ‘°λ₯Ό μν μ μ‘° λ°©λ²
granted -
US 2023203129
ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
granted -
IL 300192
Manufacturing of dimeric contrast agents
granted -
US 2023040008
ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
granted -
CA 3217274
PROCEDE DE FABRICATION D'UNE SOLUTION D'UN COMPLEXE DE GADOLINIUM
granted -
US 2022370646
PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTS
granted -
US 2022348923
CA-IX APTAMERS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
granted -
US 2022062444
PHARMACEUTICAL COMPOSITIONS COMPRISING GD-COMPLEXES AND POLYARYLENE ADDITIVES
granted -
CN 113874050
MODIFIED CYANINE DYES AND CONJUGATES THEREOF
granted -
CA 3162611
COMPLEXES DE FER ET SELS DE CEUX-CI UTILISES EN TANT QU'AGENTS DE CONTRASTE POUR IRM
granted -
CN 112996764
CHELATING AAZTA CONJUGATES AND COMPLEXES THEREOF
granted -
US 2020376145
GADOLINIUM BEARING PCTA-BASED CONTRAST AGENTS
granted -
IL 265680
Dimeric contrast agents
granted -
EP 3442949
KONTRASTMITTEL
granted -
US 2018362511
DIMERIC CONTRAST AGENTS
granted -
EP 3394627
RATIOMETRISCH GEPULSTE CEST-BILDGEBUNG
granted -
IL 259901
Functionalized macrocycle chelators, complexes containing same and uses thereof as contrast agents
granted -
US 2018036436
ETHYLENEDIAMINETETRAACETIC ACID BIS(AMIDE) DERIVATIVES AND THEIR RESPECTIVE COMPLEXES WITH MN(II) ION FOR USE AS MRI CONTRAST AGENT
granted
Frequently asked questions
How many patents does Bracco Imaging S.p.A have?
25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Bracco Imaging S.p.A patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.